The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Open accessAbstract
Protein Phosphatase 2A (PP2A) is an important and ubiquitously expressed serine threonine phosphatase and regulates the function by dephosphorylating many critical cellular molecules like Akt, p53, c-Myc and β-catenin. It plays a critical role in cellular processes, such as cell proliferation, signal transduction and apoptosis. Structurally, it is multifarious as it is composed of catalytic, scaffold and regulatory subunits. The catalytic and scaffold subunits have two isoforms and the regulatory subunit has four different families containing different isoforms. The regulatory subunit is the most diverse with temporal and spatial specificity. PP2A undergoes post-translational modifications (i.e. phosphorylation and methylation), which in turn, regulates its enzymatic activity. Aberrant expression, mutations and somatic alterations of the PP2A scaffold and regulatory subunits have been observed in various human malignancies, including lung, breast, skin and colon cancer, highlighting its role as a ‘tumor suppressor’. This review is focused on the structural complexity of serine/threonine phosphatase PP2A and summarizes its expression pattern in cancer. Additionally, the PP2A interacting and regulatory proteins and substrates are also discussed. Finally, the mouse models developed to understand the biological role of PP2A subunits in an in vivo model system are also reviewed in this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Protein tyrosine phosphatases: from genes, to function, to disease
Tonks, N. K. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2039 · Cited by 1,677
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Regulation of protein kinase cascades by protein phosphatase 2A
Millward, T. A., Zolnierowicz, S., & Hemmings, B. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01375-4 · Cited by 793
CIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 1×
“Endogenous CIP2A (cancerous inhibitor of PP2A) inhibits PP2Ac activity via interacting with c-Myc (Ser62) and stabilizes it from proteolytic degradation [49].”
BackgroundProtein serine/threonine phosphatases: structure, regulation, and functions in cell growth
Mumby, M. C., & Walter, G. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.673 · Cited by 655
Shugoshin collaborates with protein phosphatase 2A to protect cohesin
Kitajima, T. S., Sakuno, T., Ishiguro, K.-I., Iemura, S.-I., Natsume, T., Kawashima, S. A., & Watanabe, Y. (2006) · Nature · doi:10.1038/nature04663 · Cited by 597
Novel protein serine/threonine phosphatases: Variety is the spice of life
Cohen, P. T. W. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01060-8 · Cited by 505
Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 476
Gunnarsdóttir, E. D., Nandineni, M. R., Li, M., Myles, S., Gil, D., Pakendorf, B., & Stoneking, M. (2012) · Nature Communications · doi:10.1038/ncomms1401 · Cited by 461
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
PP2A: the expected tumor suppressor
Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426
Tumor progression and metastasis
Yokota, J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.497 · Cited by 426
Regulation of β-Catenin Signaling by the B56 Subunit of Protein Phosphatase 2A
Seeling, J. M., Miller, J. R., Gil, R., Moon, R. T., White, R., & Virshup, D. M. (1999) · Science · doi:10.1126/science.283.5410.2089 · Cited by 420
Kinomics: methods for deciphering the kinome
Johnson, S. A., & Hunter, T. (2005) · Nature Methods · doi:10.1038/nmeth731 · Cited by 419
McCright, B., Rivers, A. M., Audlin, S., & Virshup, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22081 · Cited by 382
Kuo, Y.-C., Huang, K.-Y., Yang, C.-H., Yang, Y.-S., Lee, W.-Y., & Chiang, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709585200 · Cited by 367
Alterations of the PPP2R1B Gene in Human Lung and Colon Cancer
Wang, S. S., Esplin, E. D., Li, J. L., Huang, L., Gazdar, A., Minna, J., & Evans, G. A. (1998) · Science · doi:10.1126/science.282.5387.284 · Cited by 363
Molecular mechanisms of theprotein serine/threonine phosphatases
Barford, D. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10060-8 · Cited by 357
TONKS, N. K., & COHEN, P. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08522.x · Cited by 329
Healy, A. M., Zolnierowicz, S., Stapleton, A. E., Goebl, M., DePaoli-Roach, A. A., & Pringle, J. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5767 · Cited by 284
Regulators of Serine / Threonine Protein Phosphatases at the Dawn of a Clinical Era?
Honkanen, R., & Golden, T. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368836 · Cited by 258
Evolution of protein phosphatases in plants and animals
Moorhead, G. B. G., De Wever, V., Templeton, G., & Kerk, D. (2009) · Biochemical Journal · doi:10.1042/bj20081986 · Cited by 254
Hemmings, B. A., Adams-Pearson, C., Maurer, F., Mueller, P., Goris, J., Merlevede, W., Hofsteenge, J., & Stone, S. R. (1990) · Biochemistry · doi:10.1021/bi00465a002 · Cited by 243
Tolstykh, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5682 · Cited by 237
Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα
Götz, J., Probst, A., Ehler, E., Hemmings, B., & Kues, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12370 · Cited by 220
Calin, G. A., di Iasio, M. G., Caprini, E., Vorechovsky, I., Natali, P. G., Sozzi, G., Croce, C. M., Barbanti-Brodano, G., Russo, G., & Negrini, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203389 · Cited by 219
Bennin, D. A., Don, A. S. A., Brake, T., McKenzie, J. L., Rosenbaum, H., Ortiz, L., DePaoli-Roach, A. A., & Horne, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111693200 · Cited by 209
Sents, W., Ivanova, E., Lambrecht, C., Haesen, D., & Janssens, V. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08579.x · Cited by 204
Protein phosphatase 2A in Saccharomyces cerevisiae: effects on cell growth and bud morphogenesis.
Ronne, H., Carlberg, M., Hu, G. Z., & Nehlin, J. O. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4876 · Cited by 204
The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase
Sablina, A. A., Chen, W., Arroyo, J. D., Corral, L., Hector, M., Bulmer, S. E., DeCaprio, J. A., & Hahn, W. C. (2007) · Cell · doi:10.1016/j.cell.2007.03.047 · Cited by 203
Type 2A protein phosphatase, the complex regulator of numerous signaling pathways
Zolnierowicz, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00424-x · Cited by 200
Moreno, C. S., Park, S., Nelson, K., Ashby, D., Hubalek, F., Lane, W. S., & Pallas, D. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5257 · Cited by 194
Comparison of heterotrimeric protein phosphatase 2A containing different B subunits.
Kamibayashi, C., Estes, R., Lickteig, R. L., Yang, S. I., Craft, C., & Mumby, M. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32138-5 · Cited by 190
Role of serine/threonine protein phosphatase 2A in cancer
Schönthal, A. H. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00561-4 · Cited by 186
Longin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., & Janssens, V. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704059200 · Cited by 184
Zhuo, S., Clemens, J. C., Stone, R. L., & Dixon, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47184-0 · Cited by 178
α4 Associates with Protein Phosphatases 2A, 4, and 6
Chen, J., Peterson, R. T., & Schreiber, S. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8792 · Cited by 174
Protein phosphatase 2A — a ‘ménage à trois’
Mayer-Jaekel, R. E., & Hemmings, B. A. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90219-4 · Cited by 165
High Complexity in the Expression of the B′ Subunit of Protein Phosphatase 2A0
Csortos, C., Zolnierowicz, S., Bakó, E., Durbin, S. D., & DePaoli-Roach, A. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2578 · Cited by 163
TUNG, H. Y. L., ALEMANY, S., & COHEN, P. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb08833.x · Cited by 162
A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation
Ito, A., Kataoka, T. R., Watanabe, M., Nishiyama, K., Mazaki, Y., Sabe, H., Kitamura, Y., & Nojima, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.562 · Cited by 159 · cited 2×
“Moreover, association of increased cell motility and invasiveness due to altered PP2A activity was observed in BL6 mouse melanoma cells [65], lung carcinoma [66] and head and neck squamous carcinoma [67].”
BackgroundAlberts, A. S., Thorburn, A. M., Shenolikar, S., Mumby, M. C., & Feramisco, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.388 · Cited by 158
Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus
Li, X., Yost, H. J., Virshup, D. M., & Seeling, J. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.4122 · Cited by 156
Autoregulation of Protein Phosphatase Type 2A Expression
Baharians, Z., & Schönthal, A. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19019 · Cited by 154
Ruediger, R., Pham, H. T., & Walter, G. (2001) · Oncogene · doi:10.1038/sj.onc.1204059 · Cited by 154
Chiang, C.-W., Harris, G., Ellig, C. L., Masters, S. C., Subramanian, R. R., Shenolikar, S., Wadzinski, B. E., & Yang, E. (2001) · Blood · doi:10.1182/blood.v97.5.1289 · Cited by 154
Critical Role for Protein Phosphatase 2A Heterotrimers in Mammalian Cell Survival
Strack, S., Cribbs, J. T., & Gomez, L. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408015200 · Cited by 144
Li, X., Scuderi, A., Letsou, A., & Virshup, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3674-3684.2002 · Cited by 137
Kar, S., Palit, S., Ball, W. B., & Das, P. K. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0715-4 · Cited by 130
Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes.
Ariño, J., Woon, C.-W., Brautigan, D. L., Miller, T. B., & Johnson, G. L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4252 · Cited by 130
Structural Basis of PP2A Inhibition by Small t Antigen
Cho, U., Morrone, S. R., Sablina, A. A., Arroyo, J. D., Hahn, W. C., & Xu, W. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050202 · Cited by 129
Identification of a Novel Protein Phosphatase 2A Regulatory Subunit Highly Expressed in Muscle
Tehrani, M. A., Mumby, M. C., & Kamibayashi, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5164 · Cited by 123
CIP2A is a target of bortezomib in human triple negative breast cancer cells
Tseng, L.-M., Liu, C.-Y., Chang, K.-C., Chu, P.-Y., Shiau, C.-W., & Chen, K.-F. (2012) · Breast Cancer Research · doi:10.1186/bcr3175 · Cited by 122
Yan, Z., Fedorov, S. A., Mumby, M. C., & Williams, R. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1021-1029.2000 · Cited by 122
Zołnierowicz, S., Csoŕtos, C., Bondor, J., Verin, A. D., Mumby, M. C., & DePaoli-Roach, A. A. (1994) · Biochemistry · doi:10.1021/bi00205a023 · Cited by 121
Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2PP2A/SET
Arnaud, L. T., Chen, S., Liu, F., Li, B., Khatoon, S., Grundke, I., & Iqbal, K. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.020 · Cited by 121
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
Guo, L., Ji, X., Gao, H., Zhao, J., Xu, J., Sun, Z.-J., Deng, Y., Shi, S., Feng, Y., Zhu, Y.-Q., et al. (2012) · Nature Communications · doi:10.1038/ncomms1675 · Cited by 116
Louis, J. V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Longin, S., Zwaenepoel, K., Pijnenborg, R., Landrieu, I., Lippens, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018777108 · Cited by 112
Tissue‐specific expression of mRNAs encoding α‐ and β‐catalytic subunits of protein phosphatase 2A
Khew-Goodall, Y., & Hemmings, B. A. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80493-9 · Cited by 102
Vimentin Dephosphorylation by Protein Phosphatase 2A Is Modulated by the Targeting Subunit B55
Turowski, P., Myles, T., Hemmings, B. A., Fernandez, A., & Lamb, N. J. C. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.6.1997 · Cited by 100
Ruediger, R., Ruiz, J., & Walter, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05744-11 · Cited by 98
ZHOU, J., PHAM, H. T., RUEDIGER, R., & WALTER, G. (2003) · Biochemical Journal · doi:10.1042/bj20021244 · Cited by 95
Constant Expression and Activity of Protein Phosphatase 2A in Synchronized Cells
Ruediger, R., Hood, J., Mumby, M. C., & Walter, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4282-4285.1991 · Cited by 91
Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor.
Carlson, S. G., Eng, E., Kim, E. G., Perlman, E. J., Copeland, T. D., & Ballermann, B. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101873 · Cited by 90
Janssens, V., Jordens, J., Stevens, I., Van Hoof, C., Martens, E., De Smedt, H., Engelborghs, Y., Waelkens, E., & Goris, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211717200 · Cited by 89 · cited 1×
“PR72 requires calcium binding in two EFX domains (Domain required for Nkd to interact with the basic/PDZ domains of fly Dsh or vertebrate Dvl proteins in the yeast two-hybrid assay) and this binding facilitates conformational changes in protein structure to interact with the PR65 scaffold subunit [32].”
BackgroundRuvolo, P. P., Qui, Y. H., Coombes, K. R., Zhang, N., Ruvolo, V. R., Borthakur, G. M., Konopleva, M. Y., Andreeff, M., & Kornblau, S. M. (2011) · Leukemia · doi:10.1038/leu.2011.146 · Cited by 89
Analysis of subunit isoforms in protein phosphatase 2A holoenzymes from rabbit and Xenopus.
Hendrix, P., Turowski, P., Mayer-Jaekel, R. E., Goris, J., Hofsteenge, J., Merlevede, W. J., & Hemmings, B. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53179-3 · Cited by 88
Leulliot, N., Quevillon‐Chéruel, S., Sorel, I., de la Sierra-Gallay, I. L., Collinet, B., Graille, M., Blondeau, K., Bettache, N., Poupon, A., Janin, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311484200 · Cited by 88
Cloning and characterization of Bδ, a novel regulatory subunit of protein phosphatase 2A
Strack, S., Chang, D., Zaucha, J. A., Colbran, R. J., & Wadzinski, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01377-0 · Cited by 85
Kalla, C., Scheuermann, M. O., Kube, I., Schlotter, M., Mertens, D., Döhner, H., Stilgenbauer, S., & Lichter, P. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.02.005 · Cited by 84
McConnell, J. L., Gomez, R. J., McCorvey, L. R. A., Law, B. K., & Wadzinski, B. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210406 · Cited by 80
The structure of protein phosphatase 2A is as highly conserved as that of protein phosphatase I
Orgad, S., Brewis, N., Alphey, L., Axton, M., Dudai, Y., & Cohen, P. T. W. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81435-q · Cited by 77
Campbell, K. S., Auger, K. R., Hemmings, B. A., Roberts, T. M., & Pallas, D. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3721-3728.1995 · Cited by 75
Cayla, X., Hoof, C. A. V., Bosch, M., Waelkens, E., Vandekerckhove, J. S., Peeters, B., Merlevede, W. J., & Goris, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40733-2 · Cited by 73
Berry, M., & Gehring, W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2946 · Cited by 69
Flicking the switches: phosphorylation of serine/threonine protein phosphatases
Brautigan, D. L. (1995) · Seminars in Cancer Biology · doi:10.1006/scbi.1995.0028 · Cited by 65
Cheng, Y., Liu, W., Kim, S.-T., Sun, J., Lu, L., Sun, J., Zheng, S. L., Isaacs, W. B., & Xu, J. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.05.002 · Cited by 64 · cited 1×
“Somatic copy number changes or germ line sequence variation was thought to be the reason for the deletion [88].”
BackgroundColella, S., Ohgaki, H., Ruediger, R., Yang, F., Nakamura, M., Fujisawa, H., Kleihues, P., & Walter, G. (2001) · International Journal of Cancer · doi:10.1002/ijc.1423 · Cited by 61
PPP2R1A mutations are common in the serous type of endometrial cancer
Nagendra, D., Burke, J. J., Maxwell, G. L., & Risinger, J. I. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20850 · Cited by 60
Bhardwaj, A., Singh, S., Srivastava, S. K., Honkanen, R. E., Reed, E., & Singh, A. P. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1096 · Cited by 60
Effects of Regulatory Subunits on the Kinetics of Protein Phosphatase 2A
Price, N. E., & Mumby, M. C. (2000) · Biochemistry · doi:10.1021/bi0008478 · Cited by 56
Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse
Gu, P., Qi, X., Zhou, Y., Wang, Y., & Gao, X. (2012) · genesis · doi:10.1002/dvg.20815 · Cited by 51 · cited 1×
“Interestingly, Ppp2cb knockout mice model showed no abnormal phenotype [93].”
BackgroundMolecular cloning of a 74‐kDa regulatory subunit (B″ or δ) of human protein phosphatase 2A
Tanabe, O., Nagase, T., Murakami, T., Nozaki, H., Usui, H., Nishito, Y., Hayashi, H., Kagamiyama, H., & Takeda, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01500-0 · Cited by 51
Shouse, G., Nobumori, Y., & Liu, X. (2010) · Oncogene · doi:10.1038/onc.2010.161 · Cited by 49
Kobayashi, N., Reiser, J., Schwarz, K., Sakai, T., Kriz, W., & Mundel, P. H. (2001) · Histochemistry and Cell Biology · doi:10.1007/s004180000242 · Cited by 48
Rapid dephosphorylation of p107 following UV irradiation
Voorhoeve, P. M., Watson, R. J., Farlie, P. G., Bernards, R., & Lam, E. W. ‐. (1999) · Oncogene · doi:10.1038/sj.onc.1202289 · Cited by 47
Kamnasaran, D., Chen, C., Devriendt, K., Mehta, L., & Cox, D. W. (2005) · Genomics · doi:10.1016/j.ygeno.2005.01.010 · Cited by 46
HOOF, C. V., Cayla, X., Bosch, M., Merlevede, W. J., & Goris, J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.00899.x · Cited by 43
Glenn, G. M., & Eckhart, W. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1945-1952.1993 · Cited by 43
Esplin, E. D., Ramos, P., Martinez, B., Tomlinson, G. E., Mumby, M. C., & Evans, G. A. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20284 · Cited by 43
Walter, G., & Ruediger, R. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19057 · Cited by 42
Myles, T., SCHMIDT, K., Evans, D. R., Cron, P. D., & Hemmings, B. A. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570225 · Cited by 40
Young, M. R., Kolesiak, K., & Meisinger, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10491 · Cited by 38
Protein serine/threonine phosphatases as binding proteins for okadaic acid
Nagao, M., Shima, H., Nakayasu, M., & Sugimura, T. (1995) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00143-3 · Cited by 33
Damuni, Z., Xiong, H., & Li, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00981-3 · Cited by 30
Identification of proteins interacting with the catalytic subunit of PP2A by proteomics
Lee, W., Kim, D., Lee, M., & Choi, K. (2006) · PROTEOMICS · doi:10.1002/pmic.200600480 · Cited by 27
Nuclear Export and Centrosome Targeting of the Protein Phosphatase 2A Subunit B56α
Flegg, C. P., Sharma, M., Medina‐Palazon, C., Jamieson, C., Galea, M. A., Brocardo, M. G., Mills, K. M., & Henderson, B. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.093294 · Cited by 26
Dupont, W. D., Breyer, J. P., Bradley, K. M., Schuyler, P. A., Plummer, W. D., Sanders, M. E., Page, D. L., & Smith, J. R. (2009) · Cancer · doi:10.1002/cncr.24702 · Cited by 26
Everett, A. D., Kamibayashi, C., & Brautigan, D. L. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00262.2001 · Cited by 24
Francia, G., Poulsom, R., Hanby, A. M., Mitchell, S. D., Williams, G., McKee, P. H., & Hart, I. R. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<709::aid-ijc14>3.0.co;2-r · Cited by 20
Janssens, V., HOOF, C. V., Martens, E., BAERE, I. D., Merlevede, W. J., & Goris, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01486.x · Cited by 16
Clonal divergence in lung cancer development is associated with allelic loss on chromosome 4
Banerjee, A. K., Read, C., Griffiths, M. H. G., George, P. J., & Rabbitts, P. H. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20472 · Cited by 13
Baek, S., & Seeling, J. M. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-139 · Cited by 12
Cited by
Current treatment strategies for inhibiting mTOR in cancer
Chiarini, F., Evangelisti, C., McCubrey, J. A., & Martelli, A. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.004 · Cited by 275
Huang, K.-L., Jee, D., Stein, C. B., Elrod, N. D., Henriques, T., Mascibroda, L. G., Baillat, D., Russell, W. K., Adelman, K., & Wagner, E. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.016 · Cited by 184
REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling
Dennis, M. D., Coleman, C. S., Berg, A., Jefferson, L. S., & Kimball, S. R. (2014) · Science Signaling · doi:10.1126/scisignal.2005103 · Cited by 159
Modulation of Phosphoprotein Activity by Phosphorylation Targeting Chimeras (PhosTACs)
Chen, P.-H., Hu, Z., An, E., Okeke, I., Zheng, S., Luo, X., Gong, A., Jaime-Figueroa, S., & Crews, C. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.1c00693 · Cited by 130
Di Conza, G., Trusso Cafarello, S., Loroch, S., Mennerich, D., Deschoemaeker, S., Di Matteo, M., Ehling, M., Gevaert, K., Prenen, H., Zahedi, R. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.051 · Cited by 119
Metadata
- Authors
- Seshacharyulu, P., Pandey, P., Datta, K., & Batra, S. K.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 335
- Issue
- 1
- Pages
- 9-18
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1992060900
- Cited by
- 481
- References
- 110
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.